Crestor Study Highlights Corruptness of Modern Medical System
Note to all Knowledge of Health readers: the recent publication of a report in The New England Journal of Medicine regarding the use of rosuvastatin (Crestor) among healthy American adults for prevention of heart disease represents evidence for:
1. The treatment of "health" with a "side effect pill." Crestor has the worst side effect profile among all statin drugs and its approval was initially declined by the FDA.
2. The collaboration by the news media, medical publications, health authorities and industry to foist off pseudo-science upon the public. Would you take an expensive pill ($3.45 a day), when you are perfectly healthy, a pill that is only going to prevent a heart attack in less than 1 in 100 users, and places you at risk for liver toxicity, memory impairment and muscle wasting. The best you could possibly get out of this pill is that it would induce memory loss and you would forget to take it. Health authorities know how to read scientific literature. There is a concerted effort to mislead the public here. The maker of Crestor wants to expand the use of statin drugs to adults with low or normal cholesterol levels. Their target market is 7.7 million middle-aged Americans, which would reap $8.8 billion in annual sales.
3. The report published in The New England Journal of Medicine failed to distinguish mortality from non-mortal heart disease, so we don't really know how many lives would be saved. Their estimation is 1 life saved for every $500,000 spent. If this drug therapy were taken by the masses and it prevented even half of the 1 million heart attacks annually it would bankrupt most health insurance plans.
4. The New England Journal of Medicine report provides more evidence that modern medicine is no longer affordable to most Americans.
5. The report will likely spur TV advertising which the FDA and the FTC will permit, without mention that side effects are more likely to occur than any health benefit and that the chances of the pill preventing a cardiac death is less than 1 in 100. This means false advertising will continue to be permitted by the FDA and FTC when it comes to drugs, but not dietary supplements. Doctors will prescribe this problematic drug because it will bring patients to their offices via TV advertising. The masses will fall for this false advertising, as they did for Vioxx which led to the premature death of 20,000 Americans. The public must have gumption and begin to resist recommendations made by their doctors.
6. The Crestor study represents disease substitution, not disease prevention, as it increased the risk for doctor-diagnosed diabetes.
7. The concerted effort to publish studies in the Journal of the American Medical Association on the same day as the release of the Crestor study, studies that falsely show vitamin C and E do not prevent heart disease, is more evidence of modern medicine's orchestrated efforts to dismiss alternatives to drugs. The dosage of vitamin C (500 mg) used in that study could not significantly raise blood levels for more than 2-4 hours, and the dosage of vitamin E (400 mg) was not correlated with the oxidative stress levels of the subjects in the study. Therefore, both studies are bogus.
You are urged by this writer to practice self care and to advise your family and loved ones that adoption of modern medicine is hazardous to one's health. The Crestor study adds to the growing list of bogus health recommendations by public health authorities, namely the use of statin drugs for heart disease, ineffective flu vaccines to prevent winter-time illness, and the use of sunscreens which have only served to increase skin cancer-related mortality. The US healthcare system is an unaffordable, self-serving, dysfunctional system.
-Bill Sardi, Knowledge of Health, Inc.
Labels: Crestor, FDA, FTC, Health, pill, rosuvastatin, studies